Alerts will be sent to your verified email
Verify EmailAAREYDRUGS
|
Aarey Drugs & Pharma
|
Natural Capsules
|
BDH Inds
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
4.4 % | 9.1 % | 14.8 % |
|
5yr average Equity Multiplier
|
2.28 | 1.91 | 1.46 |
|
5yr Average Asset Turnover Ratio
|
1.58 | 0.61 | 0.89 |
|
5yr Avg Net Profit Margin
|
1.23 % | 6.68 % | 11.59 % |
|
Price to Book
|
1.32 | 0.84 | 2.89 |
|
P/E
|
54.57 | 0.0 | 20.93 |
|
5yr Avg Cash Conversion Cycle
|
60.21 Days | 25.72 Days | -27.79 Days |
|
Inventory Days
|
21.8 Days | 27.47 Days | 31.79 Days |
|
Days Receivable
|
122.43 Days | 125.88 Days | 116.74 Days |
|
Days Payable
|
103.05 Days | 118.63 Days | 156.43 Days |
|
5yr Average Interest Coverage Ratio
|
3.59 | 7.96 | 78.47 |
|
5yr Avg ROCE
|
8.53 % | 10.02 % | 19.81 % |
|
5yr Avg Operating Profit Margin
|
1.54 % | 14.83 % | 14.91 % |
|
5 yr average Debt to Equity
|
0.22 | 0.51 | 0.1 |
|
5yr CAGR Net Profit
|
-9.19 % | -38.15 % | 7.83 % |
|
5yr Average Return on Assets
|
1.94 % | 4.68 % | 10.19 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
44.8 % | 51.26 % | 49.7 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-5.23 % | -5.3 % | 0.04 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Aarey Drugs & Pharma
|
Natural Capsules
|
BDH Inds
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|